Gene: EEA1
Official Full Name: early endosome antigen 1provided by HGNC
Gene Summary: Enables 1-phosphatidylinositol binding activity; GTP-dependent protein binding activity; and protein homodimerization activity. Involved in endocytosis and vesicle fusion. Located in cytosol and early endosome membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03559 | EEA1 Knockout cell line (HeLa) | Human | EEA1 | 1:3~1:6 | Negative | Online Inquiry |
KO03560 | EEA1 Knockout cell line (HCT 116) | Human | EEA1 | 1:2~1:4 | Negative | Online Inquiry |
KO03561 | EEA1 Knockout cell line (HEK293) | Human | EEA1 | 1:3~1:6 | Negative | Online Inquiry |
KO03562 | EEA1 Knockout cell line (A549) | Human | EEA1 | 1:3~1:4 | Negative | Online Inquiry |
EEA1 Gene Knockout Cell Lines are advanced research tools specifically designed for the study of endosomal transport and membrane trafficking within cellular systems. These cell lines have been genetically modified to disrupt the EEA1 gene, which encodes the early endosomal antigen 1 protein critical for the maturation of early endosomes. By eliminating the expression of this protein, researchers can rigorously investigate the role of EEA1 in various cellular processes, including receptor recycling, signal transduction, and pathogenesis of diseases linked to endosomal dysfunction.
The primary function of EEA1 as a tethering factor facilitates the fusion of early endosomes, a crucial step in the endocytic pathway. The knockout of the EEA1 gene leads to significant alterations in endosomal morphology, dynamics, and cargo trafficking, enabling scientists to assess the downstream effects on cellular health and function. The detailed mechanistic insights gained from studies utilizing these knockout cell lines provide invaluable contributions to understanding cellular pathways involved in diseases such as cancer, neurodegeneration, and infectious diseases.
Compared to traditional methods for studying gene function, EEA1 Gene Knockout Cell Lines offer distinct advantages, including the ability to manipulate and observe the direct consequences of gene loss in a controlled environment. This specificity allows researchers to produce more accurate and reproducible data. Furthermore, the use of knockout cell lines accelerates the screening of therapeutic effects and the validation of drug targets, streamlining the path to discovery in pharmaceutical research.
The strategic importance of these cell lines is underscored in both basic research and clinical applications, providing pivotal insights into biological processes that can drive therapeutic innovations. Researchers and clinicians alike will find great value in the precision and specificity afforded by EEA1 Gene Knockout Cell Lines, making them an essential addition to any laboratory focused on cellular biology.
Our company specializes in the development of high-quality, genetically modified cell lines, and we are committed to supporting scientific advancement by providing products that meet rigorous standards for quality and reliability. Our expertise ensures that researchers are equipped with the tools necessary to push the boundaries of discovery in cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.